Se prevé que el tamaño del mercado de biopsia líquida alcance los 8.123,85 millones de dólares para 2027, frente a los 3.861,49 millones de dólares de 2019. Se estima que la CAGR del mercado de biopsia líquida crecerá un 9,9 % entre 2020 y 2027.
La biopsia líquida es una tecnología revolucionaria que está abriendo diversas perspectivas. La tecnología consiste en el aislamiento y detección de células tumorales circulantes, ADN tumoral y exosomas, que proporcionan información genómica sobre los pacientes con cáncer. La biopsia líquida se utiliza en el diagnóstico del cáncer para estudiar la respuesta o resistencia a determinados tratamientos. Las diferentes muestras que se utilizan para la biopsia líquida son sangre, orina y otras muestras, incluidas heces y otras. Además, las células tumorales circulantes, los exosomas y el ácido nucleico libre son los biomarcadores circulantes que se utilizan para detectar cánceres. La biopsia líquida ofrece ventajas como bajo costo, precisión, resultados rápidos y detección temprana sobre las técnicas de diagnóstico tradicionales, lo que convierte a la biopsia líquida en una técnica popular entre los pacientes. Debido a los avances tecnológicos en cuanto a viabilidad y tiempo de respuesta, ha ganado amplia atención como una técnica alternativa no invasiva a la biopsia de tejido en pacientes con cáncer.
La biopsia líquida global El mercado está segmentado según el producto y la calidad. servicios, muestra, biomarcador circulante, aplicación, usuario final y geografía. El mercado mundial de biopsias líquidas está segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. El informe de mercado de biopsia líquida ofrece información y un análisis en profundidad del mercado, enfatizando varios parámetros como las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis competitivo de los principales actores del mercado a nivel mundial. La previsión del mercado de biopsia líquida se estudia de 2019 a 2027.
regiones lucrativas para el mercado de biopsia líquida
Información sobre el mercado
Iniciativas gubernamentales y de organizaciones de salud globales para impulsar el mercado global de biopsia líquida
La prueba de biopsia líquida se realiza para detectar el cáncer en una etapa temprana . La prueba se puede realizar en una muestra de sangre para identificar células cancerosas en el torrente sanguíneo o en el ADN extraído de células tumorales. El gobierno toma varias iniciativas para la detección temprana del cáncer. Por ejemplo, los Institutos Nacionales de Salud (NIH) iniciaron una iniciativa llamada Colaboración precompetitiva en biopsia líquida para la evaluación temprana del cáncer. Sus propósitos son establecer un programa de asociación público-privada para desarrollar tecnologías, métodos y ensayos nuevos o validar los existentes para capturar y cuantificar células, ARN, ADN o exosomas asociados a tumores en fluidos corporales de pacientes con una enfermedad en etapa temprana o aquellos en alto riesgo. Hace hincapié en la detección temprana del cáncer, en distinguir entre cánceres agresivos y no agresivos, y en diferenciar las enfermedades benignas del cáncer. Los países europeos también están tomando iniciativas para la detección precoz del cáncer. Por ejemplo, la Iniciativa de Medicamentos Innovadores financió el proyecto CANCER-ID. Se trata de una asociación público-privada entre la UE y la industria farmacéutica europea, que incluye 38 socios de 13 países europeos, además de grupos de EE.UU. y una empresa de Singapur. Estos socios se reúnen para desarrollar y validar procedimientos operativos estandarizados para biopsias líquidas. Estas crecientes iniciativas para la biopsia líquida impulsarán el crecimiento del mercado de la biopsia líquida.
Producto y características Información basada en servicios
Basada en productos y características. Servicios, el mercado mundial de biopsia líquida se segmenta en equipos, reactivos y componentes. kits y servicios. Los reactivos y El segmento de kits tuvo la mayor participación del mercado en 2019 y se prevé que registre la CAGR más alta del mercado durante el período de pronóstico.
Mercado de biopsia líquida, por Productos y servicios: 2019 y 2027
Información basada en muestras
Según la muestra, el mercado de biopsias líquidas se segmenta en sangre y orina. basado, y otras muestras. En 2019, el segmento a base de sangre tuvo la mayor participación del mercado y se estima que registrará la CAGR más alta del mercado durante el período de pronóstico debido a sus notables ventajas, como que la muestra de biopsia líquida a base de sangre no es invasiva e indolora. , reduce el costo y el tiempo de diagnóstico con respecto al método convencional.
Información basada en biomarcadores circulantes
Basado en biomarcadores circulantes, el mercado de biopsia líquida es segmentado en células tumorales circulantes (CTC), exosomas y ácido nucleico libre. El segmento de células tumorales circulantes (CTC) tuvo la mayor participación del mercado en 2019 y se estima que registrará la CAGR más alta durante el período previsto. El segmento CTC domina otros segmentos porque puede usarse repetidamente y proporcionar información más útil sobre el riesgo de células cancerosas, la progresión de la enfermedad y el tratamiento.
Información basada en aplicaciones
Según la aplicación, el mercado de la biopsia líquida se segmenta en pruebas prenatales no invasivas (NIPT), oncología, diagnóstico de trasplantes y otras aplicaciones. El segmento de oncología tuvo la mayor participación del mercado en 2019. Sin embargo, se estima que el segmento de pruebas prenatales no invasivas (NIPT) registrará la CAGR más rápida del mercado durante el período de pronóstico.
Información basada en el usuario final
Según el usuario final, el mercado de la biopsia líquida se segmenta en académicos y académicos. institutos de investigación, hospitales, laboratorios de referencia y otros usuarios finales. El segmento de hospitales tuvo la mayor participación de mercado en 2019. Sin embargo, se estima que el segmento de laboratorios de referencia registrará la CAGR más alta durante el período de pronóstico.
Perspectivas estratégicas< /h3>
Los lanzamientos de productos y las colaboraciones son algunos desarrollos orgánicos, estrategias adoptadas por los actores del mercado global de biopsia líquida para expandir su presencia en todo el mundo y satisfacer la creciente demanda. Fusión y Se prevé que la adquisición, colaboración y asociación por parte de los actores operativos en el mercado con el objetivo de cerrar la brecha entre la oferta y la demanda desempeñen un papel importante en el crecimiento del mercado durante el período de pronóstico. A continuación se enumeran algunos de los recientes desarrollos clave del mercado:
En noviembre de 2019, Thermo Fisher Scientific lanzó un producto llamado Oncomine Precision Assay, un innovador panel pan-cáncer para la plataforma Genexus. Es probable que realice perfiles genómicos a partir de muestras de tejido fijadas con formalina e incluidas en parafina (FFPE) y de biopsia líquida con un solo ensayo.
En agosto de 2018, Exact Sciences Corp. firmó una asociación con Pfizer para promover Colorguard en EE. UU. Pfizer ha ayudado con representantes de ventas a promocionar la prueba entre los médicos y los sistemas de salud durante las campañas de marketing.
La pandemia de COVID-19 ha afectado significativamente al mercado de la biopsia líquida. Debido al creciente número de pacientes con COVID-19, se retrasó el suministro de kits y pruebas de diagnóstico; Se impuso un bloqueo mundial y se cerraron todas las operaciones comerciales. COVID-19 ha impactado profundamente la cantidad de pacientes que se someten a pruebas de detección, diagnóstico y tratamiento del cáncer. El aumento de la presión debido al aumento de la tasa de hospitalización de pacientes con COVID-19 llevó a la remodelación de muchos hospitales y departamentos, incluidas las clínicas de oncología, para el tratamiento de pacientes con COVID-19. También ralentizó los ensayos clínicos y el desarrollo de fármacos. Lucence Diagnostics, con sede en California y conocida como un actor del mercado en la industria de la salud que desarrolla biopsias líquidas, fue desviada para fabricar kits para COVID-19. Por lo tanto, la generalización de COVID-19 limitó el crecimiento del mercado de biopsias líquidas. Sin embargo, la flexibilización de las restricciones y la reanudación de las empresas por parte de las empresas ayudarán a que el mercado crezca a un ritmo constante durante el período previsto.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Liquid biopsy is a revolutionary technology that is opening up various perspectives. The technology consists of isolation and detection of circulating tumor cells, circulating tumor DNA and exosomes, which provides genomic information of the cancer patients. Liquid biopsy are used in cancer diagnosis in order to study response or resistance to given treatments.
The growth of the market is attributed to some key driving factors such as increasing prevalence of cancer and growing geriatric population. However, low sensitivity of liquid biopsy is likely to pose a negative impact on the market during the forecast years.
The North American region holds the largest market for the liquid biopsy. The United States held the largest market for liquid biopsy mean market and is expected to grow due to factors such as Increasing incidence of cancer, growing need for diagnosing cancer, increasing competition between the market player, high R&D spending, and government grants for research institutes to develop new diagnostics.
The List of Companies - Liquid Biopsy Market
- Biocept, Inc
- Bio-Rad Laboratories Inc
- LungLife AI, Inc
- Exosome Diagnostics
- F. Hoffmann-la Roche ltd
- Exact Sciences Corporation
- Inivata Ltd
- MDxHealth
- Qiagen
- Thermo Fisher Scientific Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)